GENESIS BIOTECHNOLOGY GROUP Trademark

Trademark Overview

On Wednesday, April 14, 2010, a trademark application was filed for GENESIS BIOTECHNOLOGY GROUP with the United States Patent and Trademark Office. The USPTO has given the GENESIS BIOTECHNOLOGY GROUP trademark a serial number of 85013557. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 14, 2023. This trademark is owned by Medical Diagnostic Laboratories, LLC. The GENESIS BIOTECHNOLOGY GROUP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding waste treatment and the treatment of waste in the marine industry
genesis biotechnology group

General Information

Serial Number85013557
Word MarkGENESIS BIOTECHNOLOGY GROUP
Filing DateWednesday, April 14, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 14, 2023
Registration Number4462943
Registration DateTuesday, January 7, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 25, 2013

Trademark Statements

Description of MarkThe mark consists of the stylized term "GENESIS" above the phrase "BIOTECHNOLOGY GROUP" with a sylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letters "GENES" and "S" in "GENESIS"; the color beige appears in the fourteen spheres representing atoms; the color black appears in the phrase "BIOTECHNOLOGY GROUP", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.
Pseudo MarkGENESIS BIO TECHNOLOGY GROUP
Indication of Colors claimedThe color(s) maroon, beige, black and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOTECHNOLOGY GROUP"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding waste treatment and the treatment of waste in the marine industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 19, 2010
Primary Code042
First Use Anywhere DateTuesday, March 8, 2011
First Use In Commerce DateTuesday, March 8, 2011

Trademark Owner History

Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameGENESIS BIOTECHNOLOGY GROUP, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameMedical Diagnostic Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 14, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 14, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, September 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 6, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, January 7, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 7, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 7, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 7, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 8, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, January 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 7, 2014REGISTERED-PRINCIPAL REGISTER
Friday, December 6, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 5, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Sunday, December 1, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 6, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 2, 2013USE AMENDMENT FILED
Wednesday, November 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, August 20, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 5, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, April 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 24, 2012NON-FINAL ACTION E-MAILED
Wednesday, October 24, 2012NON-FINAL ACTION WRITTEN
Monday, October 1, 2012ASSIGNED TO EXAMINER
Wednesday, September 26, 2012SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, March 23, 2012REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, September 18, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 16, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 10, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 10, 2010LETTER OF SUSPENSION E-MAILED
Friday, September 10, 2010SUSPENSION LETTER WRITTEN
Friday, August 20, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 20, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 17, 2010ASSIGNED TO LIE
Wednesday, August 4, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 2, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 26, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 26, 2010NON-FINAL ACTION E-MAILED
Monday, July 26, 2010NON-FINAL ACTION WRITTEN
Wednesday, July 21, 2010ASSIGNED TO EXAMINER
Tuesday, April 20, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Monday, April 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 17, 2010NEW APPLICATION ENTERED

Related Keywords

group biotechnology genesis such research disease waste treatment throughput screening compounds chemical discovery